T1	Intervention 190 313	recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human erythropoietin (rHuEPO)
T2	Intervention 447 465	concurrent control
T3	Intervention 473 529	historical control patients treated with rhGM-CSF alone.